(Q61904787)
Statements
A First Human Dose Trial Investigating the Safety, Tolerability and Pharmacokinetics of Single Doses of Oral NNC0113-2023 in Healthy Male Subjects (English)
0 references
9 August 2018
0 references
5 December 2018
0 references
40
0 references
18 year
0 references
45 year
0 references